Paul Horstmeier - 22 Mar 2023 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Reporting relationship: Chief Operating Officer
Issuer ticker: HCAT
Reported as of: 22 Mar 2023
Net transaction value: +$221,000
SEC form: 4
Accepted by SEC: 24 Mar 2023, 17:56:55 UTC
Prior SEC filing: 03 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Daniel Orenstein, as Attorney-in-Fact

Key filing fact

Paul Horstmeier filed Form 4 for Health Catalyst, Inc. (HCAT) on 24 Mar 2023.

Key facts

This page summarizes Paul Horstmeier's Form 4 filing for Health Catalyst, Inc. (HCAT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Mar 2023, 17:56.

Change

Previous filing in this sequence was filed on 03 Mar 2023.
Current net transaction value: +$221,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCAT transaction

Common Stock

Options Exercise

Transaction value: $221,000
Shares: +50,000
Change %: +32%
Price: $4.42
Shares after: 204,880
Date: 22 Mar 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HCAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -50,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $4.42
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the 50,000 shares underlying the options vested in an annual installment on July 1, 2014 and the remaining balance vested in equal monthly installments until the option vested in full on July 1, 2017.